Phase IV, Proof of Concept Study to Evaluate Tysabri Effectiveness in RRMS Patient Bladder Function
Phase of Trial: Phase IV
Latest Information Update: 05 Jun 2015
At a glance
- Drugs Natalizumab (Primary)
- Indications Multiple sclerosis
- Focus Proof of concept; Therapeutic Use
- Acronyms TRUST
- Sponsors Biogen Idec
- 19 Oct 2011 Results presented at the 5th Joint Triennial Congress of the European and Americas Committees for Treatment and Research in Multiple Sclerosis (ECTRIMS and ACTRIMS), according to a Biogen Idec and Elan Corporation media release.
- 14 Jul 2011 Actual end date (Mar 2011) added as reported by ClinicalTrials.gov.
- 14 Jul 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.